A child presents with massive hepatomegaly and hypoglycemia. There is no improvement in blood glucose on administration of glucagon. The probable diagnosis is
**Core Concept**
The child's presentation of massive hepatomegaly and hypoglycemia, combined with a lack of response to glucagon administration, suggests a disorder of glycogen metabolism. Glucagon typically stimulates glycogen breakdown to glucose, releasing glucose into the bloodstream. A failure to respond to glucagon implies a problem with the glycogenolysis pathway.
**Why the Correct Answer is Right**
The child's symptoms are consistent with Glycogen Storage Disease Type I (GSD I), also known as von Gierke's disease. This disorder is caused by a deficiency of the enzyme glucose-6-phosphatase, which is essential for the conversion of glucose-6-phosphate to glucose. As a result, glycogen is not broken down to glucose, leading to hypoglycemia. The massive hepatomegaly is due to the accumulation of glycogen in the liver. The lack of response to glucagon is a key diagnostic feature of GSD I, as glucagon is unable to stimulate glycogen breakdown in the absence of functional glucose-6-phosphatase.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is likely referring to Glycogen Storage Disease Type III (GSD III), also known as Cori's disease. While GSD III also involves glycogen metabolism, it is caused by a deficiency of the debranching enzyme, leading to a different clinical presentation and glucagon response.
**Option B:** This option is likely referring to Glycogen Storage Disease Type IV (GSD IV), also known as Andersen's disease. GSD IV is caused by a deficiency of the branching enzyme, leading to an accumulation of abnormal, amylopectin-like glycogen. The clinical presentation and glucagon response in GSD IV are different from those in GSD I.
**Option C:** This option is likely referring to Glycogen Storage Disease Type VI (GSD VI), also known as Hers' disease. GSD VI is caused by a deficiency of the liver phosphorylase enzyme, leading to a mild form of glycogen storage disease. The clinical presentation and glucagon response in GSD VI are different from those in GSD I.
**Option D:** This option is likely referring to Glycogen Storage Disease Type II (GSD II), also known as Pompe disease. GSD II is caused by a deficiency of the acid alpha-glucosidase enzyme, leading to an accumulation of glycogen in muscles. The clinical presentation and glucagon response in GSD II are different from those in GSD I.
**Clinical Pearl / High-Yield Fact**
Glycogen Storage Disease Type I (GSD I) is a rare but critical disorder that requires prompt diagnosis and management to prevent long-term complications. The lack of response to glucagon is a key diagnostic feature, and treatment involves a strict diet and medication to manage hypoglycemia.
**Correct Answer: A. Glycogen Storage Disease Type I (GSD I)**